Earnings History Data for Vanda Pharmaceuticals Inc. (VNDA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. The Company has three product candidates in clinical development. It's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia & bipolar disorder & is in a Phase III clinical trial for schizophrenia. It's second product candidate, is a compound for the treatment of insomnia & depression which is currently in a Phase III clinical trial for insomnia. It's third product candidate, is a compound for the treatment of excessive sleepiness & is ready for a Phase II clinical trial.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
07-02-2024 AH VNDA Vanda Pharmaceuticals Inc. 199.64 -0.04 -0.09 0.12 Vanda Pharmaceuticals GAAP EPS of -$0.04 beats by $0.05, revenue of $45.27M beats by $8.27M
[2/7/2024 4:14 PM]
4.07 0.43 
(11.68%)
3.70 0.06 
(1.65%)
3.30 - 8.15 2,473,246 870,000 5,213
27-07-2023 AH VNDA Vanda Pharmaceuticals Inc. 369.37 0.03 -0.13 0.05 Vanda Pharmaceuticals GAAP EPS of $0.03, revenue of $46.06M
[7/27/2023 4:03 PM]
5.93 -0.53 
(-8.13%)
6.46 0.0 
(0.00%)
5.75 - 11.30 841,979 480,000 27,527
03-05-2023 AH 4:00 PM ET
(May 3)
VNDA Vanda Pharmaceuticals Inc. 369.36 0.06 0.00 -0.11 Vanda Pharmaceuticals reports Q1 results
[5/3/2023 4:46 PM]
6.87 0.48 
(7.43%)
6.39 0.0 
(0.00%)
5.75 - 11.90 553,809 520,000 45,765
08-02-2023 AH 4:00 PM ET
(Feb 8)
VNDA Vanda Pharmaceuticals Inc. 432.91 0.12 0.08 0.12 Vanda Pharmaceuticals GAAP EPS of $0.12 beats by $0.04, revenue of $64.5M misses by $3.1M
[2/8/2023 4:04 PM]
7.23 0.08 
(1.12%)
7.15 0.0 
(0.00%)
6.73 - 14.15 588,199 510,000 30,407
02-11-2022 AH 4:00 PM ET
(Nov 2)
VNDA Vanda Pharmaceuticals Inc. 592.20 0.06 0.10 0.14 Vanda Pharmaceuticals GAAP EPS of $0.06, revenue of $65.32M
[11/2/2022 4:50 PM]
10.16 -0.15 
(-1.45%)
10.31 0.0 
(0.00%)
9.24 - 21.44 254,549 400,000 11,991
03-08-2022 AH 4:10 PM ET
(Aug 3)
VNDA Vanda Pharmaceuticals Inc. 619.69 0.05 0.11 0.17 Vanda Pharmaceuticals GAAP EPS of $0.05, revenue of $64.39M
[8/3/2022 4:03 PM]
10.27 -0.53 
(-4.91%)
10.80 0.0 
(0.00%)
9.24 - 21.44 269,061 310,000 22,288
05-05-2022 AH 4:00 PM ET
(May 5)
VNDA Vanda Pharmaceuticals Inc. 577.32 -0.11 -0.01 0.15 Vanda Pharmaceuticals GAAP EPS of -$0.11 misses by $0.10, revenue of $60.19M beats by $2.19M
[5/5/2022 4:26 PM]
9.60 -0.20 
(-2.04%)
9.60 0.0 
(0.00%)
9.24 - 21.86 532,441 550,000 27,492
23-02-2022 AH 4:00 PM ET
(Feb 23)
VNDA Vanda Pharmaceuticals Inc. 747.10 0.12 0.09 0.15 Vanda Pharmaceuticals GAAP EPS of $0.12, revenue of $68.01M
[2/23/2022 4:04 PM]
13.78 0.58 
(0.00%)
11.69 -1.38 
(-10.56%)
11.20 - 21.86 758,447 517,545 24,920
03-11-2021 AH 4:00 PM ET
(Nov 3)
VNDA Vanda Pharmaceuticals Inc. 1,070 0.14 0.20 0.11 Vanda Pharmaceuticals EPS misses by $0.04, misses on revenue
[11/3/2021 4:13 PM]
18.17 -2.97 
(-14.05%)
18.13 -0.04 
(-0.22%)
11.41 - 21.86 1,111,898 650,000 1,802
28-07-2021 AH 4:00 PM ET
(Jul 28)
VNDA Vanda Pharmaceuticals Inc. 1,090 0.17 0.17 0.16 Vanda Pharmaceuticals EPS beats by $0.03, misses on revenue
[7/28/2021 4:07 PM]
17.89 -1.64 
(-8.40%)
19.53 0.0 
(0.00%)
9.00 - 21.86 444,771 300,000 10,969
05-05-2021 AH 4:00 PM ET
(May 5)
VNDA Vanda Pharmaceuticals Inc. 922.33 0.15 0.14 0.01 Vanda Pharmaceuticals EPS beats by $0.01
[5/5/2021 4:06 PM]
17.51 0.93 
(5.61%)
17.51 0.0 
(0.00%)
9.00 - 20.51 496,331 290,000 5,158
10-02-2021 AH 4:00 PM ET
(Feb 10)
VNDA Vanda Pharmaceuticals Inc. 829.13 0.15 0.10 0.08 Vanda Pharmaceuticals EPS beats by $0.01, beats on revenue
[2/10/2021 4:08 PM]
18.61 3.20 
(20.77%)
16.29 0.88 
(5.71%)
7.12 - 19.42 3,930,544 406,140 2,235
28-10-2020 AH 4:00 PM ET
(Oct 28)
VNDA Vanda Pharmaceuticals Inc. 570.01 0.11 0.08 1.84 Vanda Pharmaceuticals EPS beats by $0.01, misses on revenue
[10/28/2020 4:02 PM]
10.99 0.90 
(8.97%)
10.81 0.72 
(7.19%)
7.12 - 17.85 889,197 403,671 2,760
05-08-2020 AH 4:00 PM ET
(Aug 5)
VNDA Vanda Pharmaceuticals Inc. 549.87 0.16 0.08 0.21 Vanda Pharmaceuticals EPS beats by $0.12, beats on revenue
[8/5/2020 4:06 PM]
11.40 0.38 
(3.45%)
11.02 0.0 
(0.00%)
7.12 - 17.85 299,854 551,550 442,124
06-05-2020 AH VNDA Vanda Pharmaceuticals Inc. 630.30 0.01 0.01 -0.01 0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0